Investor mix
4 investors on record; lead investors include DBJ Capital.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 3 | 75% |
| Other / undisclosed | 1 | 25% |
Developing small molecule therapies for renal, metabolic and cardiovascular diseases
4 investors on record; lead investors include DBJ Capital.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 3 | 75% |
| Other / undisclosed | 1 | 25% |